Secukinumab (Cosentyx, Novartis) should be available on the NHS in England as a treatment option for moderate-to-severe hidradenitis suppurativa, the National Institute for Health and Care Excellence ...
Meta-Analysis: Suicide Risk Not Increased With Isotretinoin In fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results